Global solar inverter market is expected to contract for two consecutive years post-2024. China’s solar inverter market is ...

Novartis is on the final straight to approval of its spinal muscular atrophy (SMA) gene therapy Zolgensma in the EU, after getting a recommendation for approval from the CHMP. The positive opinion ...

Roche is hoping to undercut hugely expensive rivals after the FDA approved its oral spinal muscular atrophy (SMA) drug Evrysdi (risdiplam). Evrysdi is the third treatment approved for SMA, an ...

As a writer for Forbes Home since 2021, Emily specializes in writing about home warranties, solar installations, car transportation and moving companies. With a background in journalism and experience ...

As the United States stock market experiences a fourth consecutive session of gains, buoyed by better-than-expected GDP data and record highs in commodities like gold and silver, investors are keenly ...